CLINICAL_TRIALS
trial_result
· 2019-07-19
Clinical Trial Update: A Study of Regorafenib in Advanced Pancreatic Cancer Patients [Phase 2]
Summary
Phase 2 clinical trial update of regorafenib in advanced pancreatic cancer; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-07-19